Biotech | December 08, 2021
SPARC partners with Visiox for ophthalmic drugs
SPARC will be eligible to receive an upfront payment, milestone payments and royalty on sales, in addition to 10% equity in Visiox
SPARC will be eligible to receive an upfront payment, milestone payments and royalty on sales, in addition to 10% equity in Visiox
This is the fourth facility from the company to receive this registration
Working under the Ministry of Ayush, NMPB is mandated to coordinate all matters relating to medicinal plants and support policies and programs for growth of trade, export, conservation, and cultivation of medicinal plants
The company plans to expand their capacity to meet the needs of pharma and biotech industries
Approximately five kg tumor was removed in the eight-hour long complicated surgery
It plans to add over 1000 employees over the next six months
Investment in single-use endoscopes, digital solutions, and endoluminal therapies expected
Healtherbs helps in restoring the desired energy levels for daily activity and immunity
_256_384.jpg)
Ind-Ra expects IPM revenue growth of over 12% yoy for FY22.
Fujifilm India will be providing healthcare Imaging devices and equipment’s to increase the standards of the veterinary care in India.
Subscribe To Our Newsletter & Stay Updated
